StocksFundsScreenerSectorsWatchlists
CL

CL - Colgate-Palmolive Co Stock Price, Fair Value and News

85.81USD-0.19 (-0.22%)Market Closed

Market Summary

CL
USD85.81-0.19
Market Closed
-0.22%

CL Stock Price

View Fullscreen

CL RSI Chart

CL Valuation

Market Cap

70.6B

Price/Earnings (Trailing)

30.71

Price/Sales (Trailing)

3.63

EV/EBITDA

18.29

Price/Free Cashflow

18.86

CL Price/Sales (Trailing)

CL Profitability

Operating Margin

58.21%

EBT Margin

17.43%

Return on Equity

377.67%

Return on Assets

14.03%

Free Cashflow Yield

5.3%

CL Fundamentals

CL Revenue

Revenue (TTM)

19.5B

Rev. Growth (Yr)

6.93%

Rev. Growth (Qtr)

0.71%

CL Earnings

Earnings (TTM)

2.3B

Earnings Growth (Yr)

14.3K%

Earnings Growth (Qtr)

1.41%

Breaking Down CL Revenue

Last 7 days

-2.4%

Last 30 days

-3.8%

Last 90 days

6.1%

Trailing 12 Months

12.1%

How does CL drawdown profile look like?

CL Financial Health

Current Ratio

1.11

Debt/Equity

13.5

Debt/Cashflow

0.46

CL Investor Care

Dividend Yield

2.23%

Dividend/Share (TTM)

1.91

Buy Backs (1Y)

0.87%

Diluted EPS (TTM)

2.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202318.3B18.7B19.1B19.5B
202217.5B17.7B17.7B18.0B
202116.7B17.1B17.3B17.4B
202015.9B15.9B16.2B16.5B
201915.4B15.4B15.5B15.7B
201815.7B15.8B15.6B15.5B
201715.2B15.2B15.3B15.5B
201615.7B15.5B15.4B15.2B
201517.0B16.7B16.4B16.0B
201417.4B17.4B17.4B17.3B
201317.2B17.3B17.3B17.4B
201216.9B17.0B17.0B17.1B
201115.7B16.1B16.5B16.7B
201015.7B15.7B15.7B15.6B
200915.1B14.9B14.9B15.3B
2008014.3B14.8B15.3B
200700013.8B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Colgate-Palmolive Co

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
bilbrey john p
acquired
21,206
88.36
240
-
Apr 01, 2024
norrington lorrie m
acquired
26,242
88.36
297
-
Apr 01, 2024
edwards lisa
acquired
9,366
88.36
106
-
Apr 01, 2024
newman brian
acquired
18,732
88.36
212
-
Feb 20, 2024
wallace noel r.
acquired
3,781,930
68.16
55,486
chairman, president & ceo
Feb 20, 2024
daniels jennifer
sold
-299,578
84.6745
-3,538
clo and secretary
Feb 20, 2024
wallace noel r.
sold
-5,890,890
84.2181
-69,948
chairman, president & ceo
Feb 18, 2024
malcolm gregory
sold (taxes)
-21,871
83.48
-262
evp and controller
Feb 18, 2024
kooyman john w
sold (taxes)
-59,771
83.48
-716
chief of staff
Feb 18, 2024
tsourapas panagiotis
sold (taxes)
-287,756
83.48
-3,447
grp pres, eur& developing mkts

1–10 of 50

Which funds bought or sold CL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
Boston Common Asset Management, LLC
reduced
-29.21
-4,265,000
17,030,000
0.41%
Apr 11, 2024
Ballentine Partners, LLC
added
4.88
131,128
840,707
0.02%
Apr 11, 2024
Compton Wealth Advisory Group, LLC
new
-
211,798
211,798
0.06%
Apr 11, 2024
CITY HOLDING CO
reduced
-6.11
41,115
719,032
0.11%
Apr 11, 2024
City State Bank
unchanged
-
14,000
116,000
0.05%
Apr 11, 2024
RFG Advisory, LLC
added
6.36
80,013
477,162
0.02%
Apr 11, 2024
ROCKLAND TRUST CO
reduced
-25.09
-4,050,250
22,301,200
1.18%
Apr 11, 2024
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID
sold off
-100
-210,036
-
-%
Apr 11, 2024
Pflug Koory, LLC
reduced
-10.77
2,632
331,834
0.16%
Apr 11, 2024
First Affirmative Financial Network
added
6.46
57,561
341,577
0.25%

1–10 of 50

Are Funds Buying or Selling CL?

Are funds buying CL calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CL
No. of Funds

Unveiling Colgate-Palmolive Co's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.70%
79,893,294
SC 13G/A
Jan 26, 2024
blackrock inc.
6.8%
56,170,766
SC 13G/A
Jan 25, 2024
state street corp
5.79%
47,641,721
SC 13G/A
Feb 09, 2023
vanguard group inc
9.62%
80,375,011
SC 13G/A
Feb 06, 2023
state street corp
5.97%
49,899,351
SC 13G/A
Feb 03, 2023
blackrock inc.
8.1%
68,041,416
SC 13G/A
Feb 14, 2022
state street corp
5.89%
49,608,335
SC 13G/A
Feb 09, 2022
vanguard group inc
9.11%
76,746,614
SC 13G/A
Feb 01, 2022
blackrock inc.
7.7%
65,218,485
SC 13G/A
Feb 12, 2021
state street corp
5.92%
50,722,444
SC 13G

Recent SEC filings of Colgate-Palmolive Co

View All Filings
Date Filed Form Type Document
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Mar 27, 2024
ARS
ARS
Mar 27, 2024
DEF 14A
DEF 14A
Mar 27, 2024
DEFA14A
DEFA14A
Mar 22, 2024
3
Insider Trading
Feb 20, 2024
144
Notice of Insider Sale Intent
Feb 20, 2024
4
Insider Trading

Peers (Alternatives to Colgate-Palmolive Co)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
365.5B
83.9B
-4.29% 2.35%
24.75
4.35
4.55% 3.44%
70.6B
19.5B
-3.80% 12.14%
30.71
3.63
8.29% 28.85%
49.8B
15.2B
-12.13% -44.82%
103.04
3.28
-7.33% -68.01%
24.6B
5.9B
-4.11% 12.75%
32.61
4.2
9.16% 82.56%
17.6B
7.3B
-9.40% -10.74%
220.1
2.41
3.47% -81.61%
9.4B
6.0B
-16.57% -13.63%
29.08
1.57
14.07% 132.95%
9.0B
890.1M
-21.12% 86.88%
69.86
10.15
79.24% 176.22%
MID-CAP
4.0B
1.3B
-7.68% -13.61%
26.51
3.07
21.26% 26.23%
3.0B
8.1B
-8.94% -41.27%
-7.61
0.36
-14.02% -296.95%
2.9B
872.0M
-7.61% 39.00%
-124.21
3.35
65.49% 64.15%
2.4B
2.0B
-16.60% 12.48%
14.62
1.18
-7.82% 10.32%
SMALL-CAP
1.8B
2.3B
-4.81% -16.20%
16.69
0.79
4.31% 6.67%
154.6M
191.5M
8.69% 61.38%
8.69
0.81
-1.27% 486.29%
56.1M
259.3M
-9.66% 253.33%
-1.3
0.22
-19.36% 50.71%
35.1M
10.9M
-2.92% -15.60%
13.62
3.23
-14.28% 0.46%

Colgate-Palmolive Co News

Latest updates
MarketBeat32 minutes ago

Colgate-Palmolive Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue0.7%4,9504,9154,8224,7704,6294,4554,4844,3994,4034,4144,2604,3444,3244,1533,8974,0974,0153,9283,8663,8843,811
Cost Of Revenue-1.9%2,0002,0382,0352,0582,0551,9071,9301,8271,8441,7911,7041,7071,6811,6131,5281,6321,6011,6121,5581,5971,558
Gross Profit2.5%2,9502,8772,7872,7122,5742,5482,5542,5722,5592,6232,5562,6372,6432,5402,3692,4652,4142,3162,3082,2872,253
  S&GA Expenses-1.0%1,8031,8221,7681,7581,6331,6341,6571,6411,5981,6361,5681,6051,6331,5181,3951,4731,4121,4291,3691,3651,328
EBITDA Margin-0.22*-0.17*0.17*0.19*0.20*0.20*0.21*0.22*0.25*0.26*0.27*0.27*0.27*0.26*0.26*0.26*0.26*0.26*0.26*-
Interest Expenses-50.9%56.00114--68.0039.00---------------
Income Taxes9.1%22820935314789.00210202192136172212229202222216147188167205214189
Earnings Before Taxes3.3%988956887561132892841795324853953957894967891895870794823814832
EBT Margin31.5%0.17*0.13*0.13*0.13*0.15*0.16*0.16*0.17*0.18*0.21*0.22*0.22*0.22*0.22*0.22*0.21*0.21*0.21*0.21*--
Net Income1.4%7187085023725.00618603559148634703681647698635715643578586560606
Net Income Margin42.5%0.12*0.08*0.08*0.09*0.10*0.11*0.11*0.12*0.12*0.15*0.16*0.16*0.16*0.17*0.16*0.16*0.15*0.15*0.15*--
Free Cashflow-1.4%1,1361,1527227356739695283861,1069946275989639621,026768970914644--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets2.2%16,39316,04316,22716,17315,73116,28815,71115,72315,04015,88015,99915,80115,92015,46615,14115,07015,03415,02613,15112,88312,161
  Current Assets-1.5%5,2795,3575,4375,4665,1135,2785,1604,9894,3974,6704,6524,5634,3384,3674,2124,2484,1794,3494,2554,1333,793
    Cash Equivalents1.6%966951819867775938858877832958937995888989997854883948863843726
  Inventory0.2%1,9341,9312,0392,1102,0742,0732,0121,9241,6921,6701,7001,6761,6731,5781,5241,3011,4001,3711,3221,2781,250
  Net PPE3.9%4,5824,4094,4314,3634,3074,1233,7653,7523,7303,6333,6653,6093,7163,5063,4833,4873,7503,6893,7933,8213,881
  Goodwill2.5%3,4103,3273,3733,3753,3524183,2383,2923,2843,6853,7533,7013,8243,7113,6283,5593,5089232,5362,5172,530
Liabilities-1.3%15,43615,63715,91215,74814,92515,23515,15314,99514,06914,85315,13715,13814,81914,39314,40914,72914,47614,85213,16113,09311,964
  Current Liabilities3.0%4,7414,6024,6324,4414,0044,4924,3954,5664,0514,2814,2034,5394,4044,4814,5804,4434,0384,2313,7823,8653,341
  Long Term Debt-5.4%8,2198,6908,9548,8708,7418,2197,9577,5887,1947,6827,9517,5707,3346,9716,8847,3367,3337,6466,6406,6556,354
    LT Debt, Current25.0%20.0016.0016.0015.0014.0013.0013.0012.0012.0011.0010.009.009.002562552552542.001.001.00-
    LT Debt, Non Current-5.4%8,2198,6908,9548,8708,7418,2197,9577,5887,1947,6827,9517,5707,3346,9716,8847,3367,3337,6466,6406,6556,354
Shareholder's Equity-609-24,2584314014313903,3553,2691,4661,4663,01135823,0522,6662,6231,466-21,6531,466299
  Retained Earnings2.9%25,28924,57124,25824,15324,57324,56624,34224,14924,35024,20123,94623,62423,69923,05222,73122,48122,50121,86021,65321,43621,615
  Additional Paid-In Capital1.2%3,8083,7623,6883,6033,5463,5183,4023,3553,2693,1743,0853,0112,9692,8372,6662,6232,4882,4662,3382,2412,204
Accumulated Depreciation-100.0%-5,5705,5575,4525,2765,1955,2495,2915,1695,1945,1835,0285,0354,8744,7144,6804,8304,7004,6834,5774,455
Shares Outstanding-100.0%-823827830-835834838-843844846-857857857-857858859-
Minority Interest-16.1%348415379431405431390407362436398401358420464454441498337342299
Float---63,600---66,800---68,600---62,800---61,300--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-1.4%1,1361,1527227356739695283861,1069946275989639621,026768970914644605862
  Share Based Compensation-58.3%25.0060.0023.0014.0020.0060.0016.0029.0028.0049.0020.0038.0022.0053.0016.0016.0017.0049.0017.0017.0012.00
Cashflow From Investing11.2%-143-161-174-264-173-946-341-141-130-173-147-142-111-151-58.00-459-24.00-1,863-114-98.004.00
Cashflow From Financing-17.3%-992-846-580-375-66699.00-181-204-1,106-784-550-334-951-827-833-308-1,0201,054-512-392-978
  Buy Backs-26.2%2453323711804131043814103562513413728983508.00220178360265399282

CL Income Statement

2023-12-31
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net sales$ 19,457$ 17,967$ 17,421
Cost of sales8,1317,7197,046
Gross profit11,32610,24810,375
Selling, general and administrative expenses7,1516,5656,407
Other (income) expense, net1916965
Goodwill and intangible assets impairment charges0721571
Operating profit3,9842,8933,332
Non-service related postretirement costs3608070
Interest (income) expense, net232153175
Income before income taxes3,3922,6603,087
Provision for income taxes937693749
Net income including noncontrolling interests2,4551,9672,338
Less: Net income attributable to noncontrolling interests155182172
Net income attributable to Colgate-Palmolive Company$ 2,300$ 1,785$ 2,166
Earnings per common share, basic (in dollars per share)$ 2.78$ 2.13$ 2.56
Earnings per common share, diluted (in dollars per share)$ 2.77$ 2.13$ 2.55

CL Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current Assets  
Cash and cash equivalents$ 966$ 775
Receivables (net of allowances of $80 and $70, respectively)1,5861,504
Inventories1,9342,074
Other current assets793760
Total current assets5,2795,113
Property, plant and equipment, net4,5824,307
Goodwill3,4103,352
Other intangible assets, net1,8871,920
Deferred income taxes214135
Other assets1,021904
Total assets16,39315,731
Current Liabilities  
Notes and loans payable31011
Current portion of long-term debt2014
Accounts payable1,6981,551
Accrued income taxes336317
Other accruals2,3772,111
Total current liabilities4,7414,004
Long-term debt8,2198,741
Deferred income taxes361383
Other liabilities2,1151,797
Total liabilities15,43614,925
Commitments and contingent liabilities00
Shareholders’ Equity  
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)1,4661,466
Additional paid-in capital3,8083,546
Retained earnings25,28924,573
Accumulated other comprehensive income (loss)(3,937)(4,055)
Unearned compensation0(1)
Treasury stock, at cost(26,017)(25,128)
Total Colgate-Palmolive Company shareholders’ equity609401
Noncontrolling interests348405
Total equity957806
Total liabilities and equity$ 16,393$ 15,731
CL
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
 CEO
 WEBSITEcolgatepalmolive.com
 INDUSTRYHousehold Products
 EMPLOYEES33800

Colgate-Palmolive Co Frequently Asked Questions


What is the ticker symbol for Colgate-Palmolive Co? What does CL stand for in stocks?

CL is the stock ticker symbol of Colgate-Palmolive Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Colgate-Palmolive Co (CL)?

As of Fri Apr 12 2024, market cap of Colgate-Palmolive Co is 70.63 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CL stock?

You can check CL's fair value in chart for subscribers.

What is the fair value of CL stock?

You can check CL's fair value in chart for subscribers. The fair value of Colgate-Palmolive Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Colgate-Palmolive Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Colgate-Palmolive Co a good stock to buy?

The fair value guage provides a quick view whether CL is over valued or under valued. Whether Colgate-Palmolive Co is cheap or expensive depends on the assumptions which impact Colgate-Palmolive Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CL.

What is Colgate-Palmolive Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, CL's PE ratio (Price to Earnings) is 30.71 and Price to Sales (PS) ratio is 3.63. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Colgate-Palmolive Co's stock?

In the past 10 years, Colgate-Palmolive Co has provided 0.047 (multiply by 100 for percentage) rate of return.